Antibody conjugated magnetic iron oxide nanoparticles for cancer cell separation in fresh whole blood

Biomaterials

Volumn 32, Issue 36, 2011, Pages 9758-9765

  Xu, Hengyi ^a,b   Aguilar, Zoraida P ^b   Yang, Lily ^c   Kuang, Min ^b   Duan, Hongwei ^d   Xiong, Yonghua ^a   Wei, Hua ^a   Wang, Andrew ^b  

^a NANCHANG UNIVERSITY   (China)

^b OCEAN NANOTECH LLC   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Cancer cells; Cell sorting; Immunomagnetic separation; Iron oxide; Magnetic nanoparticles

Indexed keywords

CANCER CELLS; CELL SORTING; CELL SURFACES; EFFICIENT PROCESS; ENRICHMENT FACTORS; EPITHELIAL GROWTH; HUMAN BREAST CANCER CELLS; HUMAN CANCER CELLS; IMMUNOMAGNETIC SEPARATION; MAGNETIC IRON OXIDE NANOPARTICLES; MAGNETIC NANOPARTICLES; MEMBRANE PROTEINS; NANO-SIZED; TUMOR CELLS; WHOLE BLOOD;

ANTIBODIES; BLOOD; CELL CULTURE; CELL MEMBRANES; DISEASES; IRON; MAGNETIC FIELDS; NANOMAGNETICS; NANOPARTICLES;

IRON OXIDES;

ANTIBODY; CELL MEMBRANE PROTEIN; EPITHELIAL GROWTH FACTOR RECEPTOR 2; GROWTH FACTOR RECEPTOR; IRON OXIDE; IRON OXIDE MAGNETIC NANOPARTICLE; MAGNETIC NANOPARTICLE; POLYMER; UNCLASSIFIED DRUG;

ARTICLE; BLOOD; BREAST CANCER; CANCER CELL; CELL SEPARATION; CELL SURFACE; GEL ELECTROPHORESIS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

ANTIBODIES; BLOOD; BODY FLUIDS; BUFFERS; CELL LINE, TUMOR; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FERRIC COMPOUNDS; HUMANS; IMMUNOMAGNETIC SEPARATION; MAGNETIC PHENOMENA; METAL NANOPARTICLES; NANOPARTICLES; NEOPLASMS; PARTICLE SIZE; RECEPTOR, ERBB-2;

EID: 80054083074     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.08.076     Document Type: Article

References (41)

1. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics. CA Cancer J Clin 2010, 60:277-300.
2. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics. CA Cancer J Clin 2008, 58:71-96.
3. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M. Cancer statistics. CA Cancer J Clin 2009, 59:225-249.
4. Ghossein R., Bhattacharya S., Rosai J. Molecular detection of micrometastases and circulating tumor cells in solid tumors. Clin Cancer Res 1999, 5:1950-1960.
5. Gaforio J.J., Serrano M.J., Sanchez-Rovira P., Sirvent A., Delgado-Rodriguez M., Campos M., et al. Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis. Int J Cancer 2003, 107:984-990.
6. Molnar B., Ladanyi A., Tanko L., Sréter L., Tulassay Z. Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients. Clin Cancer Res 2001, 7:4080-4085.
7. Méhes G., Witt A., Kubista E., Ambros P.F. Circulating breast cancer cells are frequently apoptotic. Am J Pathol 2001, 159:17-20.
8. Meng S., Tripathy D., Frenkel E.P., Shete S., Naftalis E.Z., Huth J.F., et al. Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res 2004, 10:8152-8162.
9. Pierga J.Y., Bonneton C., Vincent-Salomon A., de Cremoux P., Nos C., Blin N., et al. Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients. Clin Cancer Res 2004, 10:1392-1400.
10. Hayes D.F., Walker T.M., Singh B., Vitetta E.S., Uhr J.W., Gross S., et al. Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer. Int J Oncol 2002, 21:1111-1117.
11. O'Hara S.M., Moreno J.G., Zweitzig D.R., Gross S., Gomella L.G., Terstappen L.W. Multigene reverse transcription-PCR profiling of circulating tumor cells in hormone-refractory prostate cancer. Clin Chem 2004, 50:826-835.
12. Allard W.J., Matera J., Miller M.C., Repollet M., Connelly M.C., Rao C., et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004, 10:6897-6904.
13. Liberti P.A., Rao C.G., Terstappen L.W. Optimization of ferrofluids and protocols for the enrichment of breast tumor cells in blood. J Magn Magn Mater 2001, 225:301-307.
14. Berois N., Varangot M., Osinaga E., Babino A., Caignault L., Musé I., et al. Detection of rare human breast cancer cells. Comparison of an immunomagnetic separation method with immunocytochemistry and RT-PCR. Anticancer Res 1997, 17:2639-2646.
15. Berry C.C., Wells S., Charles S., Curtis A.S. Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. Biomaterials 2003, 24:4551-4557.
16. Mapara M.Y., Körner I.J., Hildebrandt M., Bargou R., Krahl D., Reichardt P., et al. Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction. Blood 1997, 89:337-344.
17. Molday R.S., MacKenzie D. Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. J Immunol Methods 1982, 52:353-367.
18. Miltenyi S., Müller W., Weichel W., Radbruch A. High gradient magnetic cell separation with MACS. Cytometry 1990, 11:231-238.
19. 4 nanocrystals. Science 2006, 314:964-967.
20. Martin V.M., Siewert C., Scharl A., Harms T., Heinze R., Ohl S., et al. Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS. Exp Hematol 1998, 26:252-264.
21. Safarík I., Safaríková M. Use of magnetic techniques for the isolation of cells. J Chromatogr B Biomed Sci Appl 1999, 722:33-53.
22. Pamme N., Wilhelm C. Continuous sorting of magnetic cells via on-chip free-flow magnetophoresis. Lab Chip 2006, 6:974-980.
23. Xu R. Particle characterization: light scattering methods 2001, Kluwer Academic Publishers, Dordrecht, pp. 223-83.
24. Tong X., Yang L., Lang J.C., Zborowski M., Chalmers J.J. Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood. Cytometry B Clin Cytom 2007, 72:310-323.
25. Yu W.W., Falkner J.C., Yavuz C.T., Colvin V.L. Synthesis of monodisperse iron oxide nanocrystals by thermal decomposition of iron carboxylate salts. Chem Commun (Camb) 2004, 2306-2307.
26. Gao X., Cui Y., Levenson R.M., Chung L.W., Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004, 22:969-976.
27. Chithrani B.D., Ghazani A.A., Chan W.C. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 2006, 6:662-668.
28. Yu S., Chow G.M. Carboxyl group (-CO2H) functionalized ferrimagnetic iron oxide nanoparticles for potential bio-applications. J Mater Chem 2004, 14:2781-2786.
29. Majewski P., Thierry B. Functionalized magnetite nanoparticles-synthesis, properties, and bio-applications. Crit Rev Solid State Mater Sci 2007, 32:203-215.
30. Hirsch L.R., Jackson J.B., Lee A., Halas N.J., West J.L. A whole blood immunoassay using gold nanoshells. Anal Chem 2003, 75:2377-2381.
31. Derfus A.M., Chan W.C., Bhatia S.N. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 2004, 4:11-18.
32. Smith A.M., Duan H., Rhyner M.N., Ruan G., Nie S. A systematic examination of surface coatings on the optical and chemical properties of semiconductor quantum dots. Phys Chem Chem Phys 2006, 8:3895-3903.
33. Reese D.M., Slamon D.J. HER-2/neu signal transduction in human breast and ovarian cancer. Stem Cells 1997, 15:1-8.
34. Grushko T.A., Olopade O.I. Genetic markers in breast tumors with hereditary predisposition. Principles of molecular oncology 2008, 85-105. Humana press, Totowa. M.H. Bronchud, M.A. Foote, G. Giaccone, O. Olopade, P. Workman (Eds.).
35. Disis M.L., Goodell V., Schiffman K., Knutson K.L. Humoral epitope-spreading following immunization with a HER-2/neu peptide based vaccine in cancer patients. J Clin Immunol 2004, 24:571-578.
36. Sarup J.C., Johnson R.M., King K.L., Fendly B.M., Lipari M.T., Napier M.A., et al. Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growth. Growth Regul 1991, 1:72-82.
37. Lewis G.D., Figari I., Fendly B., Wong W.L., Carter P., Gorman C., et al. Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies. Cancer Immunol Immunother 1993, 37:255-263.
38. Lee J., Dull T.J., Lax I., Schlessinger J., Ullrich A. HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor. EMBO J 1989, 8:167-173.
39. Inglis D.W., Riehn R.R., Austin R.H., Sturm J.C. Continuous microfluidic immunomagnetic cell separation. Appl Phys Lett 2004, 85:5093.
40. Zborowski M., Sun L., Moore L.R., Williams P.S., Chalmers J.J. Continuous cell separation using novel magnetic quadrupole flow sorter. J Magn Magn Mater 1999, 194:224-230.
41. von Schönfeldt V., Krishnamurthy H., Foppiani L., Schlatt S. Magnetic cell sorting is a fast and effective method of enriching viable spermatogonia from Djungarian hamster, mouse, and marmoset monkey testes. Biol Reprod 1999, 61:582-589.